Citation: Navarrete, J.; Hughes, C.A.; Yuksel, N.; Schindel, T.J.; Yamamura, S.; Terajima, T.; Sriboonruang, T.; Patikorn, C.; Anantachoti, P. Community Pharmacists’ Experiences and Attitudes towards the Provision of Sexual and Reproductive Health Services: An International Survey. Healthcare 2023, 11, 1530. https://doi.org/10.3390/ healthcare11111530 Academic Editor: Georges Adunlin Received: 24 April 2023 Revised: 19 May 2023 Accepted: 22 May 2023 Published: 24 May 2023 Copyright: © 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https:// creativecommons.org/licenses/by/ 4.0/). healthcare Article Community Pharmacists’ Experiences and Attitudes towards the Provision of Sexual and Reproductive Health Services: An International Survey Javiera Navarrete 1 , Christine A. Hughes 1, * , Nese Yuksel 1 , Theresa J. Schindel 1 , Shigeo Yamamura 2 , Tomoko Terajima 3 , Tatta Sriboonruang 4 , Chanthawat Patikorn 4 and Puree Anantachoti 4 1 Faculty of Pharmacy and Pharmaceutical Sciences, College of Health Sciences, University of Alberta, Edmonton, AB T6G 2H1, Canada 2 Faculty of Pharmaceutical Sciences, Josai International University, Chiba 283-8555, Japan 3 Faculty of Pharmaceutical Sciences, Shonan University of Medical Sciences, Kanagawa 244-0806, Japan 4 Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok 10330, Thailand * Correspondence: christine.hughes@ualberta.ca; Tel.: +1-780-492-5903 Abstract: Access to comprehensive sexual and reproductive health (SRH) services remains a challenge worldwide. Describing community pharmacists’ SRH services in countries with different scopes of practice will aid in understanding how pharmacists view their roles and how to support them in providing needed services. A cross-sectional web-based survey was administered to pharmacists working in community pharmacies in Japan, Thailand, and Canada. The survey covered 7 SRH cate- gories: pregnancy tests, ovulation tests, contraception, emergency contraception, sexually transmitted and blood-borne infections, maternal and perinatal health, and general sexual health. Descriptive statistics were used to analyze the data. A total of 922 eligible responses were included in the analysis (Japan = 534, Thailand = 85, and Canada = 303). Most Thai and Canadian participants reported dispensing hormonal contraceptives (Thailand = 99%, Canada = 98%) and emergency contraceptive pills (Thailand = 98%, Canada = 97%). Most Japanese participants provided patient education on barrier contraceptives for men (56%) and information on the safety of medications in pregnancy (74%) and breastfeeding (76%). The majority of participants expressed interest in additional training and expanding their roles in SRH. Sharing international experiences can guide challenges faced by the evolution of pharmacists’ practice in SRH. Providing pharmacists support could help their readiness for this role. Keywords: sexual health; reproductive health; pharmacists; community pharmacy services; survey; international cooperation 1. Introduction Access to comprehensive sexual and reproductive health (SRH) services remains a challenge worldwide. According to the World Health Organization (WHO), 4.3 billion people of reproductive age worldwide will not have access to at least one SRH intervention in their lifetime [1]. More recently, the COVID-19 pandemic has significantly impacted the provision of these services [2–9]. Fear of accessing in-person care, medication shortage, suspended services and care programs have limited access to SRH services during the pandemic [2,3,8]. As the current global agenda includes ensuring accessible and high-quality SRH services for everyone [10], finding more options for access to these services is important. The evolution of pharmacy practice is an international phenomenon. Development, adoption, and integration of new roles and responsibilities by pharmacists have been the trend over the past few decades [11–13]. Balancing professional, clinical and economic considerations and adopting new roles of pharmacists are challenges for the profession worldwide [14]. Evidence for the benefits of pharmacists’ involvement in the delivery of Healthcare 2023, 11, 1530. https://doi.org/10.3390/healthcare11111530 https://www.mdpi.com/journal/healthcare